Moderna says its RSV vaccine is 84% effective in older adults
When you purchase through link on our land site , we may garner an affiliate commission . Here ’s how it works . Moderna ’s experimental respiratory syncytial virus ( RSV ) vaccine was about 84 % in effect at protecting sr. grownup from low respiratory tract disease in a late - point test , the drugmakerannouncedTuesday ( Jan. 17 ) . Moderna has yet to liberate the full test issue , but based on the company ’s analyses , it plans to render the vaccine for Food and Drug Administration approval " in the first half of 2023 , " the company announced ....